CDTX
Price:
$11.44
Market Cap:
$80.52M
Cidara Therapeutics, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of long-acting anti-infectives for the treatment and prevention of infectious diseases and oncology in the United States. The company's lead product candidate is rezafungin acetate, a novel molecule in the echinocandin class of antifungals for the treatment and prevention of invasive fungal infections, including candidemia and invasive candidiasis, which are fungal infections associated with high mortality rates. It also advances its Cloudbreak platform to develop conjugates for the prevention and treatment of influenza and other viral infections, such as RSV, HIV, and the SARS-Co...[Read more]
Industry
Biotechnology
IPO Date
2015-04-15
Stock Exchange
NASDAQ
Ticker
CDTX
According to Cidara Therapeutics, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.47. This represents a change of -76.68% compared to the average of -2.02 of the last 4 quarters.
The mean historical PE Ratio of Cidara Therapeutics, Inc. over the last ten years is -2.30. The current -0.47 PE Ratio has changed 1.94% with respect to the historical average. Over the past ten years (40 quarters), CDTX's PE Ratio was at its highest in in the March 2023 quarter at 8.41. The PE Ratio was at its lowest in in the June 2015 quarter at -5.99.
Average
-2.30
Median
-1.95
Minimum
-5.29
Maximum
-1.03
Discovering the peaks and valleys of Cidara Therapeutics, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 379.46%
Maximum Annual PE Ratio = -1.03
Minimum Annual Increase = -71.38%
Minimum Annual PE Ratio = -5.29
Year | PE Ratio | Change |
---|---|---|
2023 | -3.03 | 70.70% |
2022 | -1.77 | 16.95% |
2021 | -1.52 | 32.04% |
2020 | -1.15 | -59.95% |
2019 | -2.87 | 178.37% |
2018 | -1.03 | -51.76% |
2017 | -2.14 | -31.74% |
2016 | -3.13 | -40.84% |
2015 | -5.29 | 379.46% |
2014 | -1.10 | -71.38% |
The current PE Ratio of Cidara Therapeutics, Inc. (CDTX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-2.11
5-year avg
-2.07
10-year avg
-2.30
Cidara Therapeutics, Inc.’s PE Ratio is less than CytomX Therapeutics, Inc. (9.19), less than ContraFect Corporation (-0.11), greater than Clearside Biomedical, Inc. (-2.17), less than GlycoMimetics, Inc. (-0.26), less than TRACON Pharmaceuticals, Inc. (0.03),
Company | PE Ratio | Market cap |
---|---|---|
9.19 | $93.74M | |
-0.11 | $1.72M | |
-2.17 | $72.50M | |
-0.26 | $10.13M | |
0.03 | $194.57K |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Cidara Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Cidara Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Cidara Therapeutics, Inc.'s PE Ratio?
How is the PE Ratio calculated for Cidara Therapeutics, Inc. (CDTX)?
What is the highest PE Ratio for Cidara Therapeutics, Inc. (CDTX)?
What is the 3-year average PE Ratio for Cidara Therapeutics, Inc. (CDTX)?
What is the 5-year average PE Ratio for Cidara Therapeutics, Inc. (CDTX)?
How does the current PE Ratio for Cidara Therapeutics, Inc. (CDTX) compare to its historical average?